Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

TNFα inhibitor-induced urticaria: a class effect.

Canu D, Seneschal J, Milpied B, Taieb A, Darrigade AS.

Eur J Dermatol. 2019 Oct 1;29(5):543-544. doi: 10.1684/ejd.2019.3625. No abstract available.

PMID:
31789277
2.

Standardizing serial photography for assessing and monitoring vitiligo: a core set of international recommendations for essential clinical and technical specifications.

van Geel N, Hamzavi I, Kohli I, Wolkerstorfer A, Lim HW, Bae JM, Lui H, Harris JE, Pandya AG, Guan STT, Abdallah M, Esmat S, Seneschal J, Speeckaert R, Grine L, Kang HY, Raboobee N, Xiang LF, Bekkenk M, Picardo M, Taieb A.

J Am Acad Dermatol. 2019 Oct 30. pii: S0190-9622(19)32978-0. doi: 10.1016/j.jaad.2019.10.055. [Epub ahead of print]

PMID:
31678332
3.

Effectiveness and safety of dupilumab for the treatment of prurigo nodularis in a French multicenter adult cohort of 16 patients.

Calugareanu A, Jachiet M, Tauber M, Nosbaum A, Aubin F, Misery L, Droitcourt C, Barbarot S, Debarbieux S, Saussine A, Bagot M, de Masson A, Sénéschal J, Staumont-Sallé D, Bouaziz JD; French Group of Research and Study in Atopic Dermatitis (Groupe de Recherche sur l'Eczéma Atopique, GREAT) from the French Society of Dermatology (SFD).

J Eur Acad Dermatol Venereol. 2019 Sep 17. doi: 10.1111/jdv.15957. [Epub ahead of print] No abstract available.

PMID:
31529718
4.

Development or Exacerbation of Head and Neck Dermatitis in Patients Treated for Atopic Dermatitis With Dupilumab.

Soria A, Du-Thanh A, Seneschal J, Jachiet M, Staumont-Sallé D, Barbarot S; GREAT Research Group.

JAMA Dermatol. 2019 Sep 4. doi: 10.1001/jamadermatol.2019.2613. [Epub ahead of print] No abstract available.

PMID:
31483439
5.

TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema.

Bosma AL, Spuls PI, Garcia-Doval I, Naldi L, Prieto-Merino D, Tesch F, Apfelbacher CJ, Arents BWM, Barbarot S, Baselga E, Deleuran M, Eichenfield LF, Gerbens LAA, Irvine AD, Manca A, Mendes-Bastos P, Middelkamp-Hup MA, Roberts A, Seneschal J, Svensson Å, Thyssen JP, Torres T, Vermeulen FM, Vestergaard C, von Kobyletzki LB, Wall D, Weidinger S, Schmitt J, Flohr C.

Br J Dermatol. 2019 Aug 24. doi: 10.1111/bjd.18452. [Epub ahead of print]

PMID:
31444799
6.

Image Gallery: Jacquet papulo-erosive dermatitis in an adult.

Darrigade AS, Milpied B, Seneschal J.

Br J Dermatol. 2019 Dec;181(6):e145. doi: 10.1111/bjd.18346. Epub 2019 Aug 7. No abstract available.

PMID:
31390051
7.

Azathioprine in combination with methotrexate: a therapeutic alternative in severe and recalcitrant forms of alopecia areata?

Mascia P, Milpied B, Darrigade AS, Seneschal J, Eyraud A, Bonamonte D, Taïeb A.

J Eur Acad Dermatol Venereol. 2019 Dec;33(12):e494-e495. doi: 10.1111/jdv.15834. Epub 2019 Aug 23. No abstract available.

PMID:
31374131
8.

An unusual presentation of Sutton's phenomenon presenting as halo cherry angioma.

Amico S, Jacquemin C, Boniface K, Jullié ML, Taieb A, Seneschal J.

J Eur Acad Dermatol Venereol. 2019 Dec;33(12):e464-e465. doi: 10.1111/jdv.15780. Epub 2019 Jul 19. No abstract available.

PMID:
31283033
9.

Low cardiovascular risk and poor quality of life associated with tobacco use and skin infections in adult atopic dermatitis: result of a French multicenter study.

Jachiet M, Nosbaum A, Staumont-Sallé D, Seneschal J, Viguier M, Soria A, Barbaud A, Carriou AC, Chuffart-Delplanque M, Darrigade AS, Fite C, de Masson A, Bagot M, Chevret S, Bouaziz JD; French Group of Research and Study in Atopic Dermatitis (GREAT) from the French Society of Dermatology (SFD).

J Eur Acad Dermatol Venereol. 2019 Dec;33(12):e451-e453. doi: 10.1111/jdv.15774. Epub 2019 Jul 22. No abstract available.

PMID:
31273834
10.

European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period.

Vestergaard C, Wollenberg A, Barbarot S, Christen-Zaech S, Deleuran M, Spuls P, Flohr C, Trzeciak M, von Kobyletzki L, Seneschal J, Paul C, Bieber T, Werfel T, Fölster-Holst R, Darsow U, Gieler U, Svensson Å, Cork M, Stalder JF, De Raeve L, Kunz B, Simon D, Chernyshov P, Hijnen D, Gelmetti C, Ring J, Taieb A, de Bruin-Weller M, Thyssen JP.

J Eur Acad Dermatol Venereol. 2019 Sep;33(9):1644-1659. doi: 10.1111/jdv.15709. Epub 2019 Jun 23.

PMID:
31231864
11.

[Ixekizumab].

Seneschal J; Groupe de recherche sur le psoriasis de la Société française de dermatologie.

Ann Dermatol Venereol. 2019 Jun - Jul;146(6-7):507-510. doi: 10.1016/j.annder.2019.04.005. Epub 2019 Jun 14. French. No abstract available.

PMID:
31204120
12.

Correlation between capillaroscopic classifications and severity in systemic sclerosis: results from SCLEROCAP study at inclusion.

Boulon C, Aiouaz S, Blaise S, Mangin M, Decamps-Le Chevoir J, Senet P, Lazareth I, Baudot N, Tribout L, Imbert B, Lapebie FX, Lacroix P, Truchetet ME, Seneschal J, Solanilla A, Skopinski S, Lazaro E, Quéré I, Pistorius MA, Le Hello C, Perez P, Carpentier P, Constans J.

Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):63-68. Epub 2019 May 30.

13.

A new phototherapy regimen during winter as an add-on therapy, coupled with oral vitamin D supplementation, for the long-term control of atopic dermatitis: study protocol for a multicentre, randomized, crossover, pragmatic trial - the PRADA trial.

Droitcourt C, Barbarot S, Maruani A, Darrieux L, Misery L, Brenaut E, Adamski H, Chabbert C, Vermersch A, Weiborn M, Seneschal J, Taïeb A, Plantin P, Maillard H, Phan A, Skowron F, Viguier M, Staumont-Salle D, Nosbaum A, Soria A, Barbaud A, Oger E, Dupuy A; Groupe de Recherche sur l’Eczéma Atopique de la Société Française de Dermatologie (GREAT).

Trials. 2019 Mar 25;20(1):184. doi: 10.1186/s13063-019-3276-9.

14.

Importance of out-of-pocket costs for adult patients with atopic dermatitis in France.

Launois R, Ezzedine K, Cabout E, Reguai Z, Merrhand S, Heas S, Seneschal J, Misery L, Taieb C.

J Eur Acad Dermatol Venereol. 2019 Oct;33(10):1921-1927. doi: 10.1111/jdv.15581. Epub 2019 Apr 10.

PMID:
30887577
15.

Cross-cultural validation of a short-form of the Vitiligo Impact Patient scale (VIPs).

Ezzedine K, Ahmed M, Tovar-Garza A, Hajj C, Whitton M, Pandya A, Altalhab S, Seneschal J, Harris J, Taieb C.

J Am Acad Dermatol. 2019 Nov;81(5):1107-1114. doi: 10.1016/j.jaad.2019.02.008. Epub 2019 Feb 11.

PMID:
30763647
16.

Disrupting the IL-36 and IL-23/IL-17 loop underlies the efficacy of calcipotriol and corticosteroid therapy for psoriasis.

Germán B, Wei R, Hener P, Martins C, Ye T, Gottwick C, Yang J, Seneschal J, Boniface K, Li M.

JCI Insight. 2019 Jan 24;4(2). pii: 123390. doi: 10.1172/jci.insight.123390. [Epub ahead of print]

17.

Vitiligo-like lesions occurring in patients receiving anti-programmed cell death-1 therapies.

Dousset L, Boniface K, Seneschal J.

G Ital Dermatol Venereol. 2019 Aug;154(4):435-443. doi: 10.23736/S0392-0488.18.06254-5. Epub 2019 Jan 16.

PMID:
30650959
18.

Vitiligo as a skin memory disease: The need for early intervention with immunomodulating agents and a maintenance therapy to target resident memory T cells.

Boniface K, Seneschal J.

Exp Dermatol. 2019 Jun;28(6):656-661. doi: 10.1111/exd.13879. Epub 2019 Feb 12. Review.

PMID:
30636075
19.

Rituximab in moderate to severe non-renal systemic lupus erythematosus: a reanalysis of the EXPLORER study.

Scherlinger M, Carcaud C, Truchetet ME, Barnetche T, Duffau P, Couzi L, Seneschal J, Blanco P, Lazaro E, Richez C.

Ann Rheum Dis. 2019 Jul;78(7):1007-1010. doi: 10.1136/annrheumdis-2018-214833. Epub 2019 Jan 4. No abstract available.

PMID:
30610064
20.

OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.

Jacquemin C, Augusto JF, Scherlinger M, Gensous N, Forcade E, Douchet I, Levionnois E, Richez C, Lazaro E, Duffau P, Truchetet ME, Seneschal J, Couzi L, Pellegrin JL, Viallard JF, Schaeverbeke T, Pascual V, Contin-Bordes C, Blanco P.

JCI Insight. 2018 Dec 20;3(24). pii: 122167. doi: 10.1172/jci.insight.122167.

21.

Imbalance of peripheral follicular helper T lymphocyte subsets in active vitiligo.

Jacquemin C, Taieb A, Boniface K, Seneschal J; FHU ACRONIM.

Pigment Cell Melanoma Res. 2019 Jul;32(4):588-592. doi: 10.1111/pcmr.12763. Epub 2019 Feb 15.

PMID:
30552832
22.

Habits and risk perception associated with sun exposure in vitiligo patients according to their participation in a patients' organization.

Bhatia B, Kechichian E, Eleftheriadou V, Castelneau JP, Seité S, Meurant JM, Hamzavi I, Lim H, Seneschal J, Taieb C, Ezzedine K.

J Eur Acad Dermatol Venereol. 2019 Mar;33(3):e100-e103. doi: 10.1111/jdv.15264. Epub 2018 Oct 17. No abstract available.

PMID:
30284740
23.

The impact of atopic dermatitis on sexual health.

Misery L, Seneschal J, Reguiai Z, Merhand S, Héas S, Huet F, Taieb C, Ezzedine K.

J Eur Acad Dermatol Venereol. 2019 Feb;33(2):428-432. doi: 10.1111/jdv.15223. Epub 2018 Sep 23.

PMID:
30160809
24.

Association of skin hyperpigmentation disorders with digital ulcers in systemic sclerosis: Analysis of a cohort of 239 patients.

Leroy V, Henrot P, Barnetche T, Cario M, Darrigade AS, Manicki P, Doutre MS, Lazaro E, Constans J, Barcat D, Vernhes JP, Richez C, Taieb A, Truchetet ME, Seneschal J; Fédération Hospitalo-Universitaire–Aquitaine's Care and Research Organisation for Inflammatory and Immune-Mediated Diseases.

J Am Acad Dermatol. 2019 Feb;80(2):478-484. doi: 10.1016/j.jaad.2018.07.033. Epub 2018 Aug 7.

PMID:
30092330
25.

Increased risk of mortality in systemic sclerosis-associated digital ulcers: a systematic review and meta-analysis.

Meunier P, Dequidt L, Barnetche T, Lazaro E, Duffau P, Richez C, Couzi L, Truchetet ME, Seneschal J; FHU ACRONIM.

J Eur Acad Dermatol Venereol. 2019 Feb;33(2):405-409. doi: 10.1111/jdv.15114. Epub 2018 Jul 17.

PMID:
29888406
26.

Delayed hypersensitivity skin reaction to hydroxychloroquine: Successful short desensitization.

Barailler H, Milpied B, Chauvel A, Claraz P, Taïeb A, Seneschal J, Darrigade AS.

J Allergy Clin Immunol Pract. 2019 Jan;7(1):307-308. doi: 10.1016/j.jaip.2018.04.041. Epub 2018 May 22. No abstract available.

PMID:
29800755
27.

Inflammatory skin eruptions induced by anti-tumour necrosis factor-α therapy differ undeniably from psoriasis or eczema.

Darrigade AS, Boniface K, Seneschal J.

Br J Dermatol. 2018 May;178(5):1007-1008. doi: 10.1111/bjd.16522. No abstract available.

PMID:
29785818
28.

Dual efficacy of dupilumab in a patient with concomitant atopic dermatitis and alopecia areata.

Darrigade AS, Legrand A, Andreu N, Jacquemin C, Boniface K, Taïeb A, Seneschal J.

Br J Dermatol. 2018 Aug;179(2):534-536. doi: 10.1111/bjd.16711. Epub 2018 Jun 15. No abstract available.

PMID:
29710431
29.

Elevated total serum IgE in vitiligo might be protective for other autoimmune diseases.

Marti A, Taieb A, Boniface K, Ezzedine K, Seneschal J.

Br J Dermatol. 2018 Oct;179(4):987-988. doi: 10.1111/bjd.16707. Epub 2018 Aug 20. No abstract available.

PMID:
29704453
30.

Patient Burden is Associated with Alterations in Quality of Life in Adult Patients with Atopic Dermatitis: Results from the ECLA Study.

Misery L, Seneschal J, Reguiai Z, Merhand S, Héas S, Huet F, Taïeb C, Ezzedine K.

Acta Derm Venereol. 2018 Jul 11;98(7):713-714. doi: 10.2340/00015555-2940. No abstract available.

31.

Hydroxychloroquine for the prevention of fetal growth restriction and prematurity in lupus pregnancy: A systematic review and meta-analysis.

Guillotin V, Bouhet A, Barnetche T, Richez C, Truchetet ME, Seneschal J, Duffau P, Lazaro E; Fédération Hospitalo-Universitaire Acronim.

Joint Bone Spine. 2018 Dec;85(6):663-668. doi: 10.1016/j.jbspin.2018.03.006. Epub 2018 Apr 6.

PMID:
29631068
32.

Cell delivery using microneedle devices: a new approach to treat depigmenting disorders.

Boniface K, Taieb A, Seneschal J.

Br J Dermatol. 2018 Mar;178(3):588-589. doi: 10.1111/bjd.16159. No abstract available.

PMID:
29595229
33.

Inflammasome Activation Characterizes Lesional Skin of Folliculitis Decalvans.

Eyraud A, Milpied B, Thiolat D, Darrigade AS, Boniface K, Taïeb A, Seneschal J.

Acta Derm Venereol. 2018 Jun 8;98(6):570-575. doi: 10.2340/00015555-2924.

34.

Recurrent erysipelas of the face with hyperimmune reaction to group C streptococcus.

Dequidt L, Jullie ML, Seneschal J, Werfel T, Taïeb A.

Br J Dermatol. 2018 Aug;179(2):524-525. doi: 10.1111/bjd.16538. Epub 2018 May 29. No abstract available.

PMID:
29526042
35.

Assessment of subclinical atherosclerosis in systemic lupus erythematosus: A systematic review and meta-analysis.

Henrot P, Foret J, Barnetche T, Lazaro E, Duffau P, Seneschal J, Schaeverbeke T, Truchetet ME, Richez C.

Joint Bone Spine. 2018 Mar;85(2):155-163. doi: 10.1016/j.jbspin.2017.12.009. Epub 2017 Dec 27.

PMID:
29288864
36.

Vitiligo-like lesions in patients receiving anti-programmed cell death-1 therapies are distinct from spontaneously occurring active vitiligo.

Boniface K, Dutriaux C, Prey S, Taieb A, Seneschal J.

J Am Acad Dermatol. 2018 Jan;78(1):e17-e18. doi: 10.1016/j.jaad.2017.08.028. No abstract available.

PMID:
29241800
37.

Predictive biological markers of systemic lupus erythematosus flares: a systematic literature review.

Gensous N, Marti A, Barnetche T, Blanco P, Lazaro E, Seneschal J, Truchetet ME, Duffau P, Richez C; FHU ACRONIM.

Arthritis Res Ther. 2017 Oct 24;19(1):238. doi: 10.1186/s13075-017-1442-6. Review.

38.

Reproducibility of capillaroscopic classifications of systemic sclerosis: results from the SCLEROCAP study.

Boulon C, Devos S, Mangin M, Decamps-Le Chevoir J, Senet P, Lazareth I, Baudot N, Tribout L, Imbert B, Blaise S, Sintes P, Lapebie FX, Lacroix P, Truchetet ME, Seneschal J, Solanilla A, Skopinski S, Lazaro E, Quéré I, Pistorius MA, Le Hello C, Perez P, Carpentier P, Constans J.

Rheumatology (Oxford). 2017 Oct 1;56(10):1713-1720. doi: 10.1093/rheumatology/kex246.

PMID:
28957554
39.

Childhood chronic prurigo: Interest in patch tests and delayed-reading skin prick tests to environmental allergens.

Maridet C, Perromat M, Miquel J, Chiaverini C, Bessis D, Lasek A, Piram M, Bursztejn AC, Abasq C, Phan A, Martin L, Bréchat B, Chong JH, Seneschal J, Taïeb A, Boralevi F; Groupe de Recherche Clinique de la Société Française de Dermatologie Pédiatrique.

J Allergy Clin Immunol. 2018 Feb;141(2):797-799.e9. doi: 10.1016/j.jaci.2017.07.049. Epub 2017 Sep 22. No abstract available.

PMID:
28943471
40.

Vitiligo Skin Is Imprinted with Resident Memory CD8 T Cells Expressing CXCR3.

Boniface K, Jacquemin C, Darrigade AS, Dessarthe B, Martins C, Boukhedouni N, Vernisse C, Grasseau A, Thiolat D, Rambert J, Lucchese F, Bertolotti A, Ezzedine K, Taieb A, Seneschal J.

J Invest Dermatol. 2018 Feb;138(2):355-364. doi: 10.1016/j.jid.2017.08.038. Epub 2017 Sep 18.

41.

Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: a systematic review of the literature.

Eyraud A, Scouppe L, Barnetche T, Forcade E, Lazaro E, Duffau P, Richez C, Seneschal J, Truchetet ME; FHU ACRONIM.

Br J Dermatol. 2018 Mar;178(3):650-658. doi: 10.1111/bjd.15993. Epub 2018 Feb 1.

PMID:
28906550
42.

A case of lichenoid and pigmented drug eruption to acetazolamide confirmed by a lichenoid patch test.

Dequidt L, Milpied B, Chauvel A, Seneschal J, Taieb A, Darrigade AS.

J Allergy Clin Immunol Pract. 2018 Jan - Feb;6(1):283-285. doi: 10.1016/j.jaip.2017.07.005. Epub 2017 Aug 26. No abstract available.

PMID:
28847654
43.

European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes.

Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio A, Mouthon L, Cutolo M, Rongioletti F, Denton CP, Rudnicka L, Frasin LA, Smith V, Gabrielli A, Aberer E, Bagot M, Bali G, Bouaziz J, Braae Olesen A, Foeldvari I, Frances C, Jalili A, Just U, Kähäri V, Kárpáti S, Kofoed K, Krasowska D, Olszewska M, Orteu C, Panelius J, Parodi A, Petit A, Quaglino P, Ranki A, Sanchez Schmidt JM, Seneschal J, Skrok A, Sticherling M, Sunderkötter C, Taieb A, Tanew A, Wolf P, Worm M, Wutte NJ, Krieg T.

J Eur Acad Dermatol Venereol. 2017 Sep;31(9):1401-1424. doi: 10.1111/jdv.14458. Epub 2017 Aug 9.

PMID:
28792092
44.

European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis.

Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio A, Mouthon L, Cutolo M, Rongioletti F, Denton CP, Rudnicka L, Frasin LA, Smith V, Gabrielli A, Aberer E, Bagot M, Bali G, Bouaziz J, Braae Olesen A, Foeldvari I, Frances C, Jalili A, Just U, Kähäri V, Kárpáti S, Kofoed K, Krasowska D, Olszewska M, Orteu C, Panelius J, Parodi A, Petit A, Quaglino P, Ranki A, Sanchez Schmidt JM, Seneschal J, Skrok A, Sticherling M, Sunderkötter C, Taieb A, Tanew A, Wolf P, Worm M, Wutte NJ, Krieg T.

J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1581-1594. doi: 10.1111/jdv.14466. Epub 2017 Aug 8.

PMID:
28786499
45.

Toxicity profiles of immunotherapy.

Cousin S, Seneschal J, Italiano A.

Pharmacol Ther. 2018 Jan;181:91-100. doi: 10.1016/j.pharmthera.2017.07.005. Epub 2017 Jul 15. Review.

PMID:
28716652
46.

[Relevance assessment of requests for antineutrophil cytoplasmic antibodies detection: Retrospective study led in Bordeaux Hospital, France].

Biscay P, Ralazamahaleo M, Lazaro E, Richez C, Seneschal J, Rigothier C, Contin-Bordes C, Duffau P.

Rev Med Interne. 2017 Oct;38(10):656-662. doi: 10.1016/j.revmed.2017.06.003. Epub 2017 Jul 6. French.

PMID:
28690094
47.

Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.

Boniface K, Seneschal J, Picardo M, Taïeb A.

Clin Rev Allergy Immunol. 2018 Feb;54(1):52-67. doi: 10.1007/s12016-017-8622-7. Review.

PMID:
28685247
48.

Respiratory infections associated with anti-TNFα agents.

Blanchard E, Truchetet ME, Machelart I, Séneschal J, Raherison-Semjen C.

Med Mal Infect. 2017 Oct;47(6):375-381. doi: 10.1016/j.medmal.2017.05.002. Epub 2017 Jun 9. Review.

PMID:
28602386
49.

MicroRNA-211 Regulates Oxidative Phosphorylation and Energy Metabolism in Human Vitiligo.

Sahoo A, Lee B, Boniface K, Seneschal J, Sahoo SK, Seki T, Wang C, Das S, Han X, Steppie M, Seal S, Taieb A, Perera RJ.

J Invest Dermatol. 2017 Sep;137(9):1965-1974. doi: 10.1016/j.jid.2017.04.025. Epub 2017 May 11.

50.

Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the TOPICOP score.

Stalder JF, Aubert H, Anthoine E, Futamura M, Marcoux D, Morren MA, Trzeciak M, Szalai Z, Veres K, Deleuran M, Vestergaard C, Boralevi F, Chu CY, De Raeve L, Svensson Å, Fölster-Holst R, Buchner M, Takaoka R, Aoki V, Chernyshov P, Chernyshova L, Murrell DF, Zhao C, Mckinster CD, Von Kobyletzky L, Eichenfield L, Totri C, Lio P, Seneschal J, Moret L, Barbarot S.

Allergy. 2017 Nov;72(11):1713-1719. doi: 10.1111/all.13189. Epub 2017 May 22.

PMID:
28439896

Supplemental Content

Loading ...
Support Center